2.435USD+3.84%Mkt Cap: 437.36M USDP/E: —Last update: 2026-06-01
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candida…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap437.36M USD
Enterprise Value355.09M USD
Revenue (TTM)0 USD
Gross Profit-86.19M USD
Net Income (TTM)-9.58M USD
Revenue/Share0.0000 USD
Last Price2.435 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees78
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.36
PEG—
EV/EBITDA-3.50
EV/Revenue—
P/SInfinity
P/B1.35
EPS (TTM)-1.14
EPS (Forward)-0.46
52W Range
0.435077% of range3.040
52W High3.040 USD
52W Low0.4350 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-8.78%
ROE-6.03%
ROA-4.28%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-103.88M USD
CapEx (TTM)848.00K USD
FCF Margin—
FCF Yield-12.26%
Net Debt-86.78M USD
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.27
Current Ratio10.25
Quick Ratio10.04
Book Value/Sh1.816 USD
Cash/Share0.7470 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)4.750 USD
Target Range2.000 USD – 8.000 USD
# Analysts4
Ownership
Shares Out.180.35M
Float97.85M
Insiders12.07%
Institutions76.91%
Short Interest
Short Ratio15.1d
Short % Float6.82%
Short % Out.6.77%
Shares Short12.21M
Short (prev mo.)10.96M
Technical
SMA 502.281 (+6.7%)
SMA 2001.385 (+75.9%)
Beta1.56
S&P 52W Chg27.94%
Avg Vol (30d)718.58K
Avg Vol (10d)873.48K
Technical Indicators
RSI (14)52.8
MACD0.0090
MACD Signal-0.0016
MACD Hist.+0.0105
BB Upper2.422 USD
BB Middle2.296 USD
BB Lower2.171 USD
BB Width10.94%
ATR (14)0.1469 USD
Vol Ratio (20d)0.82x